Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citius Pharmaceuticals Q2 EPS $(0.05) Down From $(0.04) YoY

Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

May 12, 2022

1 minute read

Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year.

Quad/Graphics Q4 EPS $0.10, Same YoY, Sales $854.60M Miss $966.00M Estimate

By Benzinga Newsdesk

Today, 11:49 PM

Quad/Graphics (NYSE:QUAD) reported quarterly earnings of $0.10 per share. This is unchanged from the same period last year. The company reported quarterly sales of $854.60 million which missed the analyst consensus

QUAD

HC Wainwright & Co. Maintains Buy on Valneva, Lowers Price Target to $32

By Benzinga Newsdesk

Today, 11:49 PM

HC Wainwright & Co. analyst Edward White maintains Valneva (NASDAQ:VALN) with a Buy and lowers the price target from $34 to $32.

VALN

What Does Delta Air Lines Debt Look Like?

By Benzinga Insights

Today, 11:49 PM

Shares of Delta Air Lines (NYSE:DAL) moved lower by 16.57% in the past three months. Before we understand the importance of debt, let us look at how much debt Delta Air Lines has.

DAL